Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report.
Postictal agitation after electroconvulsive therapy is a common and serious condition and when severe, requires prompt intervention to safeguard the patient and medical staff from the potential for mayhem and physical harm. We present a case report on the successful use of dexmedetomidine, an alpha2 agonist, in the postictal management of severe agitation in a 34-year-old morbidly obese woman, after prior modes of intervention had failed to deliver ideal conditions.
O'Brien
Elizabeth M
EM
Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Rosenquist
Peter B
PB
Kimball
James N
JN
Dunn
Gregory N
GN
Smith
Bryan
B
Arias
Lorraine M
LM
D000328:Adult; D003131:Combined Modality Therapy; D003693:Delirium / Q000150:complications; D020927:Dexmedetomidine / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D011595:Psychomotor Agitation / Q000188:drug therapy*; D016896:Treatment Outcome
D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine